BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26782465)

  • 1. Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer.
    Sun DK; Wang L; Wang JM; Zhang P
    Genet Mol Res; 2015 Dec; 14(4):18181-7. PubMed ID: 26782465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer.
    Zhou SJ; Zhuo SR; Yang XQ; Qin CX; Wang ZL
    Diagn Pathol; 2014 Aug; 9():161. PubMed ID: 25116444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum level of DKK-1 and its prognostic potential in non-small cell lung cancer.
    Dong LL; Qu LY; Chu LY; Zhang XH; Liu YH
    Diagn Pathol; 2014 Mar; 9():52. PubMed ID: 24612589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
    Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
    Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dickkopf-1 levels in Turkish patients with bladder cancer and its association with clinicopathological features.
    Kaba M; Pirincci N; Benli E; Gecit I; Gunes M; Yuksel MB; Tok A; Kemik AS
    Asian Pac J Cancer Prev; 2014; 15(1):381-4. PubMed ID: 24528060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
    Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DKK-1 in serum as a clinical and prognostic factor in patients with cervical cancer.
    Jiang T; Huang L; Zhang S
    Int J Biol Markers; 2013 Jun; 28(2):221-5. PubMed ID: 23595579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer.
    Jiang H; Fu XG; Chen YT
    Genet Mol Res; 2015 May; 14(2):5519-26. PubMed ID: 26125749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.
    Szarvas T; Jäger T; Droste F; Becker M; Kovalszky I; Romics I; Ergün S; Rübben H
    Pathol Oncol Res; 2009 Jun; 15(2):193-201. PubMed ID: 18807212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
    Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
    Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic investigations of DKK-1 and PDCD5 expression levels as independent prognostic markers of human chondrosarcoma.
    Zarea M; Mohammadian Bajgiran A; Sedaghati F; Hatami N; Taheriazam A; Yahaghi E; Shakeri M
    IUBMB Life; 2016 Jul; 68(7):597-601. PubMed ID: 27255549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Ma L; Xu Z; Xu C; Jiang X
    Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum DKK-1 in patients with gynecological cancer.
    Jiang T; Wang S; Huang L; Zhang S
    Int J Gynecol Cancer; 2009 Oct; 19(7):1177-81. PubMed ID: 19820386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
    Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
    Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.
    Rachner TD; Thiele S; Göbel A; Browne A; Fuessel S; Erdmann K; Wirth MP; Fröhner M; Todenhöfer T; Muders MH; Kieslinger M; Rauner M; Hofbauer LC
    BMC Cancer; 2014 Sep; 14():649. PubMed ID: 25182503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mir-143 in serum of bladder cancer patients and its correlation with clinical features and prognosis.
    Liu X; Zhao W; Wang X; Zhu Y; Zhou Z; Shi B
    J BUON; 2019; 24(2):791-796. PubMed ID: 31128037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma.
    Begenik H; Kemik AS; Emre H; Dulger AC; Demirkiran D; Ebinc S; Kemik O
    Hum Exp Toxicol; 2014 Aug; 33(8):785-8. PubMed ID: 24220876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between clinicopathologic variables and serum and tissue levels of dickkopf-1 in patients with rectal cancer.
    Kemik O; Kemik AS; Sumer A; Begenik H; Purisa S; Tuzun S; Kotan C
    J Investig Med; 2011 Aug; 59(6):947-50. PubMed ID: 21712726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.